The European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) has launched an extraordinary funding mechanism endowed with four million euros to strengthen surveillance, diagnosis, and treatment efforts for Ebola, in order to respond to the outbreak caused by the Bundibugyo strain currently affecting the Democratic Republic of Congo (DRC) and Uganda.
As explained by the alliance, supported by the European Union and more than 40 member countries of the EDCTP Association, this emergency instrument is integrated into a coordinated strategy that builds on the already committed investment of 73.5 million euros in Ebola, its clinical trial networks, and its work in epidemic preparedness.
Global Health EDCTP3 has emphasized that, in the coming weeks, additional resources from EDCTP Association countries and collaborating partners may be added to strengthen the response to the Ebola outbreak caused by the Bundibugyo strain, for which there is currently no approved vaccine or specific treatment.
This urgent funding mechanism will be supported by eight projects already underway funded by Global Health EDCTP3, which will be adapted to address the new outbreak through additional research and coordination activities in epidemiological surveillance, diagnosis, and therapy development.
The new actions will be structured around three priority areas. Firstly, the creation of a regional framework for Ebola surveillance and preparedness that connects surveillance centers, laboratories, community networks, and wildlife monitoring programs in affected and at-risk countries, facilitating the real-time exchange of epidemiological, clinical, and genomic information.
In parallel, efforts will be made to accelerate the validation and deployment of reliable point-of-care diagnostic tests, through a coordinated validation platform that allows for the harmonization of protocols, sharing of samples and biobanks, and testing of new diagnostic technologies in an outbreak context. Likewise, broad-spectrum therapeutic candidates will be promoted, designing a coordinated pathway to prioritize, evaluate, and advance their development.
Specifically, the emergency fund will be directed to consolidate and expand the work of three Ebola-focused projects (EBO-PEP, Ebola PREP-TBOX, EPOCA) and five networks of excellence (SINCEP-Africa, PRESERVE, EACCR4, ACT-PREP, WANETAM-4). The teams involved in these initiatives will be able to submit their proposals until July 7.
“This emergency fund will help African scientists to track, diagnose and treat the Bundibugyo strain more rapidly, protecting lives today. But stronger health systems in Africa also mean greater global security for Europe in the future. By working together now, we are stopping outbreaks before they spread and building a safer world for everyone,” highlighted the Chair of the Governing Council of Global Health EDCTP3, María Pilar Aguar Fernández.
Since the major Ebola epidemic in West Africa between 2014 and 2016, EDCTP programs have maintained sustained investment to strengthen research capabilities and the necessary resources in Africa and Europe to combat Ebola and other infectious diseases with epidemic potential. The alliance details that this effort amounts to approximately 28.7 million euros distributed across 15 projects specifically focused on Ebola, a figure that rises to approximately 124.9 million euros and 31 projects when including general preparedness initiatives, among them those aimed at anticipating a possible Ebola outbreak.